We are live on ! Find out more
CCXI

ChemoCentryx, Inc.
CCXI

Delisted

CCXI was delisted on the 19th of October, 2022.

Back to rankings

1 hedge funds and large institutions have $52 invested in ChemoCentryx, Inc. in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 212 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 217 → 1 (-216)

100% less funds holding in top 10

Funds holding in top 10: 12 → 0 (-12)

100% less capital invested

Capital invested by funds: $3.2B → $52 (-$3.2B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 212

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
-216
Holders Change %
-99.54%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-12
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
212
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$311M
2
Goldman Sachs
Goldman Sachs
New York
-$290M
3
BlackRock
BlackRock
New York
-$250M
4
UOC
UBS O'Connor
Illinois
-$141M
5
State Street
State Street
Massachusetts
-$140M
Name Holding Trade Value Shares
Change 		Change in
Stake
KWILP
101
Kiwi Wealth Investments Limited Partnership
New Zealand
– -$1.22M -49,198 Closed
Ohio Public Employees Retirement System (OPERS)
102
Ohio Public Employees Retirement System (OPERS)
Ohio
– -$2.48M -48,000 Closed
State of New Jersey Common Pension Fund D
103
State of New Jersey Common Pension Fund D
New Jersey
– -$2.48M -47,902 Closed
Two Sigma Advisers
104
Two Sigma Advisers
New York
– -$2.45M -47,341 Closed
D.E. Shaw & Co
105
D.E. Shaw & Co
New York
– -$2.41M -46,619 Closed
New York State Common Retirement Fund
106
New York State Common Retirement Fund
New York
– -$2.39M -46,272 Closed
Walleye Trading
107
Walleye Trading
New York
– -$2.34M -45,348 Closed
CS
108
Candriam SCA
Luxembourg
– -$2.34M -45,218 Closed
WAM
109
Wolverine Asset Management
Illinois
– -$2.28M -44,137 Closed
GI
110
GAMCO Investors
Connecticut
– -$2.28M -44,106 Closed
KCM
111
Kennedy Capital Management
Missouri
– -$2.24M -43,399 Closed
RJA
112
Raymond James & Associates
Florida
– -$2.12M -41,068 Closed
Walleye Capital
113
Walleye Capital
New York
– -$2.08M -40,306 Closed
AA
114
ALPS Advisors
Colorado
– -$2.01M -38,984 Closed
DTL
115
Dynamic Technology Lab
Singapore
– -$1.97M -38,208 Closed
GC
116
Guggenheim Capital
Illinois
– -$1.86M -36,026 Closed
NFGH
117
Nan Fung Group Holdings
Hong Kong
– -$1.85M -35,830 Closed
HWAM
118
Hennion & Walsh Asset Management
New Jersey
– -$1.85M -35,740 Closed
EAM
119
Erste Asset Management
Austria
– -$1.83M -35,500 Closed
SEI Investments
120
SEI Investments
Pennsylvania
– -$1.73M -33,564 Closed
MIM
121
MetLife Investment Management
New Jersey
– -$1.71M -33,135 Closed
Marshall Wace
122
Marshall Wace
United Kingdom
– -$1.59M -30,900 Closed
DekaBank Deutsche Girozentrale
123
DekaBank Deutsche Girozentrale
Germany
– -$1.55M -30,700 Closed
BPGAM
124
BTG Pactual Global Asset Management
Bermuda
– -$1.55M -30,041 Closed
AIG
125
American International Group
New York
– -$1.55M -30,004 Closed
3 4
5
6 7

CCXI Hedge Fund Activity: Q4 2022 in Review

1 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q4 2022, worth a combined $52 — down 100% from $3.2B a quarter earlier.

Sellers outnumbered buyers: 212 funds closed out of CCXI and 0 opened new positions — a net loss of 212 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $311M sold.

  • 1 institutional investor held ChemoCentryx, Inc. (CCXI) as of Q4 2022, down from 217 in Q3 2022.
  • Funds reported $52 of ChemoCentryx, Inc. stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new ChemoCentryx, Inc. positions in Q4 2022 and 212 closed out, a net change of -212 holders.
  • The largest ChemoCentryx, Inc. seller in Q4 2022 was Vanguard Group, an estimated $311M sold.

Based on aggregated 13F filings for Q4 2022.